| scholarly article | Q13442814 |
| P50 | author | Aleksander Krag | Q56849497 |
| P2093 | author name string | Flemming Bendtsen | |
| Klaus K Andersen | |||
| Hans Israelsen | |||
| Bjørn von Ryberg | |||
| P2860 | cites work | Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study | Q48677169 |
| Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. | Q51812061 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells | Q77373909 | ||
| A lactic acid-fermented oat gruel increases non-haem iron absorption from a phytate-rich meal in healthy women of childbearing age | Q79996314 | ||
| Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry | Q80928564 | ||
| The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis | Q84290217 | ||
| Inflammatory bowel disease: clinical aspects and established and evolving therapies | Q21957029 | ||
| A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29 | Q28379073 | ||
| A simple clinical colitis activity index | Q29028915 | ||
| Inflammatory bowel disease: cause and immunobiology | Q33284507 | ||
| Review article: diet and inflammatory bowel disease--epidemiology and treatment. | Q33445163 | ||
| A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome | Q33955996 | ||
| Short-chain fatty acids: ready for prime time? | Q34551412 | ||
| Prebiotics and synbiotics in clinical medicine | Q34561563 | ||
| Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis | Q35597495 | ||
| Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics | Q35787456 | ||
| Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. | Q36062992 | ||
| A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis | Q36720357 | ||
| Dietary modulation of immune function by beta-glucans | Q37068186 | ||
| Probiotics and their derivatives as treatments for inflammatory bowel disease. | Q37448522 | ||
| The normal Lactobacillus flora of healthy human rectal and oral mucosa. | Q38550433 | ||
| Colectomy rate in acute severe ulcerative colitis in the infliximab era. | Q46601124 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1773-1780 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Safety and efficacy of Profermin® to induce remission in ulcerative colitis | |
| P478 | volume | 18 |
Search more.